Characteristic | Genotype 1 (n = 163) | Genotype 3 (n = 112) | p value |
---|---|---|---|
n (%) | n (%) | ||
Male | 114 (69.9) | 87 (77.7) | 0.15 |
Age (median range, yr) | 43.0 (25–69) | 42.5 (17–67) | 0.70 |
Risk factor for HCV infection* | |||
Intravenous energetic drug | 23 (14.1) | 30 (26.8) | 0.008 |
Blood transfusion | 47 (28.8) | 24 (21.4) | 0.17 |
Intravenous illicit drug use | 22 (13.5) | 22 (19.6) | 0.17 |
Unknown risk | 58 (34.5) | 31(27.7) | 0.16 |
Others** | 18 (11.0) | 11 (9.8) | 0.75 |
ALT (median) | 62.0 | 81.5 | 0.003 |
AST (median) | 47.0 | 65.0 | 0.001 |
GT (median) | 61.0 | 70.0 | 0.58 |
Positive cryoglobulin | 88 (54.0) | 80 (71.4) | 0.001 |